Freenome
FRNM
9.36
-0.57
-5.69%
Freenome
US · FRNM
#2882 by market cap
Listed 2024
9.36
-0.57
-5.69%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Freenome
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
- CEO
- Dr. Aaron Elliott, PhD
- Fiscal year end
- 12-31
- Website
- freenome.com
Company profile
- Exchange
- US
- Symbol
- FRNM
- Market-cap rank
- #2882
- Listing date
- 2024-06-12
- Market cap
- 1.04B
- Float cap
- 465.98M
- Shares out
- 111.50M
- Float shares
- 49.78M
Sectors & themes
Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.
Freenome discussion 0 comments